Software Alternatives, Accelerators & Startups

Reglynn.eu VS Protocol Deviation

Compare Reglynn.eu VS Protocol Deviation and see what are their differences

Reglynn.eu logo Reglynn.eu

Free EU AI Act risk check for founders. Answer 32 questions about your AI product and get a personalised gap report: your risk tier, which Articles apply to your role, obligations with the correct post-Omnibus deadlines, and a prioritised fix list.

Protocol Deviation logo Protocol Deviation

eClinical platform for clinical trials
  • Reglynn.eu Landing page
    Landing page //
    2026-08-12

Reglynn turns the EU AI Act into a decision you can act on.

Most founders don't ignore the AI Act — they can't tell whether it applies to them. Finding out costs €300/hour, and free tools hand you a risk tier with no reasoning behind it.

Reglynn asks 32 questions about what your AI system does, who it affects and how it's governed, then produces a structured gap report against the current text of Regulation (EU) 2024/1689, as amended by the June 2026 Omnibus.

What the report covers

  • Your role in the value chain — provider, deployer, distributor or importer. This decides most of your obligations, and it's the question founders most often answer wrong. Deployers owe Article 26 only: no conformity assessment, no CE marking, no EU database registration.
  • GPAI / Article 53 — whether fine-tuning a foundation model has quietly made you a model provider, and a plain statement when it hasn't.
  • The Article 6(3) exemption — whether a system inside an Annex III high-risk area is actually exempt. Skipping this is why teams budget for conformity assessments they may never owe.
  • Obligations with correct deadlines — dated against the post-Omnibus text, not the pre-Omnibus dates most published guidance still carries.
  • A prioritised fix list, GDPR overlaps, and what you're already doing right.

What it isn't

A structured self-assessment — not certification, not legal advice. Reglynn is not a notified body. The report tells you where you likely stand and exactly what to verify with a qualified advisor, so that conversation starts at question 10 instead of question 1.

How it's made Your answers are analysed by an AI system against Reglynn's own question set and risk logic, then reviewed before delivery. Reglynn is itself a Limited Risk AI system under Article 50, and publishes its own self-assessment at reglynn.eu/our-ai-act-status.

One-time payment. No subscription, no account, no sales call.

  • Protocol Deviation Landing page
    Landing page //
    2022-11-18

Reglynn.eu

Website
reglynn.eu
$ Details
freemium €59 / One-off (Full Gap Report)
Platforms
Web
Release Date
2026 August
Startup details
Country
Poland
Founder(s)
Veronika Samotii
Employees
1 - 9

Reglynn.eu features and specs

  • Regulatory Focus
    The platform appears to specialize in regulatory compliance topics, which can provide targeted, relevant information for businesses navigating EU regulations.
  • EU-Specific Content
    By focusing on the EU market, the site may offer localized insights and updates that are particularly useful for companies operating within or entering the European Union.
  • Potential Niche Expertise
    A specialized platform like this could offer deeper, more specific knowledge in its niche compared to broader, general resources.
  • Simplified Access to Information
    If well-organized, the site could serve as a centralized resource for regulatory news, updates, or guidance in a single place.
  • Possible Networking Opportunities
    Depending on its structure, the site may offer forums, contact options, or partnerships that facilitate connections with regulatory experts or industry peers.
  • Provider vs deployer role analysis
    Determines whether the Act's duties are even yours before anything else is assessed. Deployers owe Article 26 only — no conformity assessment, no CE marking.
  • Article 6(3) exemption check
    Tests whether a system inside an Annex III high-risk area is actually exempt. Prevents the over-classification that makes most free checkers unusable.

Protocol Deviation features and specs

No features have been listed yet.

Analysis of Protocol Deviation

Overall verdict

  • Protocol Deviation appears to be a niche resource focused on clinical trial and research compliance topics, which can be valuable for those in the industry, though independent verification of its authority, accuracy, and update frequency is recommended before relying on it for critical decisions.

Why this product is good

  • Focuses on a specialized topic (protocol deviations in clinical research) that is often underserved by general resources
  • May offer practical guidance for handling deviations, documentation, and regulatory compliance
  • Can serve as a convenient reference point for clinical research professionals seeking quick information

Recommended for

  • Clinical research coordinators and associates managing trial compliance
  • Regulatory affairs and quality assurance professionals in life sciences
  • Sponsors, CROs, and site staff needing guidance on documenting and reporting protocol deviations
  • Students or newcomers learning about Good Clinical Practice (GCP) and trial management

Reglynn.eu videos

No Reglynn.eu videos yet. You could help us improve this page by suggesting one.

Add video

Protocol Deviation videos

Protocol Deviations

More videos:

  • Review - What Is A Protocol Deviation?
  • Review - The Differences Between Protocol Deviations and Violations In Clinical Research Both Minor and Major

Category Popularity

0-100% (relative to Reglynn.eu and Protocol Deviation)
Legal
100 100%
0% 0
Clinical Trial Management System
Risk Management
100 100%
0% 0
Clinical Trials
0 0%
100% 100

Questions & Answers

As answered by people managing Reglynn.eu and Protocol Deviation.

What makes your product unique?

Reglynn.eu's answer

Three things. It uses the correct post-Omnibus deadlines — most published guidance still carries the pre-June-2026 dates, which tells high-risk providers they're late when they aren't, and tells chatbot builders they have time when they don't. It runs the Article 6(3) exemption check, which almost no free tool does, so it won't tell you you're high-risk when the regulation says otherwise. And it publishes its own AI Act self-assessment, because Reglynn is an AI system under the regulation it assesses.

Why should a person choose your product over its competitors?

Reglynn.eu's answer

Free checkers give you a risk tier with no reasoning. Enterprise GRC platforms give you a subscription starting in the tens of thousands. A lawyer gives you an answer at €300/hour. Reglynn gives you a dated, structured document you can put in front of an enterprise procurement team — once, for €59.

It also works hard not to over-classify you. The report runs role, then GPAI, then the Article 6(3) exemption, then establishment, in that order, because assigning someone else's obligations to a deployer is what makes these tools useless.

How would you describe the primary audience of your product?

Reglynn.eu's answer

Founders, product managers and operations leads at EU or EU-serving companies with 5–50 people who ship an AI feature — chatbots, generative products, scoring or ranking models, AI-assisted screening. Typically the trigger is an enterprise prospect's legal team asking for their AI Act position in writing, with a deadline attached. Not lawyers, and not enterprises with a compliance department.

What's the story behind your product?

Reglynn.eu's answer

After the June 2026 Omnibus, the coverage said "the EU delayed the AI Act." That's half true, and it's the reassuring half. High-risk obligations moved to December 2027 — but Article 50 transparency duties were never deferred, and regulators gained fining powers on 2 August 2026.

So the group with live obligations right now is precisely the group that read "delayed" and stopped paying attention. Reglynn was built to close that gap for companies that can't put €300/hour behind finding out.

Which are the primary technologies used for building your product?

Reglynn.eu's answer

A static site on Netlify. Assessment through structured forms, with report generation via Anthropic's Claude API against Reglynn's own question set and classification logic. Delivery logging in Airtable. Analytics via GA4 with Consent Mode v2, denied by default.

Who are some of the biggest customers of your product?

Reglynn.eu's answer

Reglynn launched in August 2026 and doesn't publish customer names. Buyers are typically 10–50 person AI companies responding to an enterprise procurement or due-diligence request.

User comments

Share your experience with using Reglynn.eu and Protocol Deviation. For example, how are they different and which one is better?
Log in or Post with

What are some alternatives?

When comparing Reglynn.eu and Protocol Deviation, you can also consider the following products

RegDossier.eu - Eight free EU compliance tools. NIS2 applicability, AI Act risk and fines, DORA assessment, deadline tracker. Article-level citations, no signup.

ComplianceAgent - Free EU AI Act Article 50 Transparency Checker — five plain-language questions, instant deterministic result. No account, nothing stored.

SetAIComply - AI-Act-native compliance for European SMEs — classify AI systems, generate Annex IV docs, and stay compliant in 24 EU languages. Self-serve, from €0.

AI Act Directory - Independent directory of 187 AI governance and EU AI Act compliance vendors.

OneTrust - Privacy Management Software

Vanta - Automate compliance, simplify security.